Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Afsaneh Shirani MD, MSCI

Afsaneh Shirani MD, MSCI

Assistant Professor, Division of Multiple Sclerosis, Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska

Dr. Afsaneh Shirani is an assistant professor of neurology and a physician-scientist at the University of Nebraska Medical Center in Omaha. She earned her MD from Tehran University of Medical Sciences, Iran. Subsequently, she completed a postdoctoral fellowship in the pharmacoepidemiology of multiple sclerosis at the University of British Columbia, Vancouver, Canada, and a neurology residency at the University of Texas Southwestern Medical Center in Dallas. In 2017, she began a fellowship in MS and neuroimmunology at Washington University in St. Louis, where she also obtained a Master of Science in Clinical Investigation. Dr. Shirani’s research focuses on interventional neuroepidemiology and pharmacoepidemiology in MS. She has a particular interest in utilizing real-world data to enhance patient outcomes and is dedicated to exploring innovative approaches in disease management and neuroprotection for MS. She has authored over 45 peer-reviewed journal articles and several book chapters in the field of MS and has received awards from the MS Society of Canada, the US National MS Society, the Multiple Sclerosis International Federation, and the American Academy of Neurology, among others. Dr. Shirani uses her resources to advocate for people with MS, especially those from underserved and underrepresented populations. Additionally, she is committed to addressing health disparities and promoting equitable care for all patients.

Disclosures

Dr. Shirani serves on the editorial board of the Journal of Central Nervous System Disease, and Brain Sciences. She is also an associate editor for Frontiers in Neurology and Frontiers in Immunology and an editor for the Multiple Sclerosis section of Current Treatment Options in Neurology. She has received an honorarium for serving on the advisory medical board for TG therapeutics. 

Recent Contributions to PracticeUpdate:

  1. Sex Differences in Diagnostic Biomarkers of MS